Johnson & Johnson Share Price Buenos Aires S.E.
Equities
DJNJ3D
ARDEUT112687
Pharmaceuticals
Sales 2024 * | 8.83TCr 78,89500Cr 7,34500Cr | Sales 2025 * | 9.08TCr 81,05000Cr 7,54600Cr | Capitalization | 35TCr 3,15,86300Cr 29,40600Cr |
---|---|---|---|---|---|
Net income 2024 * | 2.2TCr 19,68100Cr 1,83200Cr | Net income 2025 * | 2.31TCr 20,62100Cr 1,92000Cr | EV / Sales 2024 * | 3.92 x |
Net cash position 2024 * | 699.71Cr 6,24800Cr 58TCr | Net cash position 2025 * | 1.98TCr 17,71900Cr 1,65000Cr | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
15.4
x | Employees | 1,31,900 |
Yield 2024 * |
3.28% | Yield 2025 * |
3.43% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
27/24/27 | 1,250 | -.--% | 9 |
23/24/23 | 1,250 | -.--% | 11 |
End-of-day quote Buenos Aires S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+37.66% | 73TCr | |
+15.67% | 33TCr | |
-0.23% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+3.88% | 16TCr | |
-2.10% | 16TCr | |
-1.31% | 12TCr |